IT1248702B - Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche - Google Patents

Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche

Info

Publication number
IT1248702B
IT1248702B IT02056290A IT2056290A IT1248702B IT 1248702 B IT1248702 B IT 1248702B IT 02056290 A IT02056290 A IT 02056290A IT 2056290 A IT2056290 A IT 2056290A IT 1248702 B IT1248702 B IT 1248702B
Authority
IT
Italy
Prior art keywords
pct
mucoregulator
preparation
pharmaceutical compositions
antitussive agent
Prior art date
Application number
IT02056290A
Other languages
English (en)
Italian (it)
Other versions
IT9020562A1 (it
IT9020562A0 (enExample
Inventor
Giuseppe Quadro
Original Assignee
Yason Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11168835&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1248702(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yason Srl filed Critical Yason Srl
Priority to IT02056290A priority Critical patent/IT1248702B/it
Publication of IT9020562A0 publication Critical patent/IT9020562A0/it
Priority to ES91911446T priority patent/ES2061252T3/es
Priority to AT91911446T priority patent/ATE113029T1/de
Priority to PCT/EP1991/001023 priority patent/WO1991018865A1/en
Priority to DE69104723T priority patent/DE69104723T2/de
Priority to JP91510028A priority patent/JPH05506450A/ja
Priority to AU79564/91A priority patent/AU644452B2/en
Priority to US07/952,838 priority patent/US5352703A/en
Priority to CA002083597A priority patent/CA2083597A1/en
Priority to EP91911446A priority patent/EP0532644B1/en
Publication of IT9020562A1 publication Critical patent/IT9020562A1/it
Publication of IT1248702B publication Critical patent/IT1248702B/it
Application granted granted Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/80—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paper (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT02056290A 1990-06-06 1990-06-06 Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche IT1248702B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT02056290A IT1248702B (it) 1990-06-06 1990-06-06 Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche
EP91911446A EP0532644B1 (en) 1990-06-06 1991-06-03 Antitussive and mucus regulating agent, a process for the preparation thereof and pharmaceutical compositions containing it
ES91911446T ES2061252T3 (es) 1990-06-06 1991-06-03 Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
AT91911446T ATE113029T1 (de) 1990-06-06 1991-06-03 Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
PCT/EP1991/001023 WO1991018865A1 (en) 1990-06-06 1991-06-03 Antitussive and mucus regulating agent, a process for the preparation thereof and pharmaceutical compositions containing it
DE69104723T DE69104723T2 (de) 1990-06-06 1991-06-03 Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
JP91510028A JPH05506450A (ja) 1990-06-06 1991-06-03 鎮咳および粘液正常化活性を有する物質、その製造方法およびこれを含有する薬剤組成物
AU79564/91A AU644452B2 (en) 1990-06-06 1991-06-03 Antitussive and mucus regulating agent, a process for the preparation thereof and pharmaceutical compositions containing it
US07/952,838 US5352703A (en) 1990-06-06 1991-06-03 Antitussive and mucus regulating agent, a process for the preparation thereof and pharmaceutical compositions containing it
CA002083597A CA2083597A1 (en) 1990-06-06 1991-06-03 Antitussive and mucus regulating agent, a process for the preparation thereof and pharmaceutical compositions containing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02056290A IT1248702B (it) 1990-06-06 1990-06-06 Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche

Publications (3)

Publication Number Publication Date
IT9020562A0 IT9020562A0 (enExample) 1990-06-06
IT9020562A1 IT9020562A1 (it) 1991-12-06
IT1248702B true IT1248702B (it) 1995-01-26

Family

ID=11168835

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02056290A IT1248702B (it) 1990-06-06 1990-06-06 Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche

Country Status (9)

Country Link
US (1) US5352703A (enExample)
EP (1) EP0532644B1 (enExample)
JP (1) JPH05506450A (enExample)
AT (1) ATE113029T1 (enExample)
CA (1) CA2083597A1 (enExample)
DE (1) DE69104723T2 (enExample)
ES (1) ES2061252T3 (enExample)
IT (1) IT1248702B (enExample)
WO (1) WO1991018865A1 (enExample)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
US9303038B2 (en) 2011-09-06 2016-04-05 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy and neurological diseases
WO2013167990A1 (en) 2012-05-07 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of depression
SG11201407300VA (en) 2012-05-07 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of neurological disorders
WO2013168021A1 (en) 2012-05-07 2013-11-14 Mahesh Kandula Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
US9309233B2 (en) 2012-05-08 2016-04-12 Cellix Bio Private Limited Compositions and methods for the treatment of blood clotting disorders
WO2013167993A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurological degenerative disorders
US9522884B2 (en) 2012-05-08 2016-12-20 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic disorders
US9266823B2 (en) 2012-05-08 2016-02-23 Cellix Bio Private Limited Compositions and methods for the treatment of parkinson's disease
US9403826B2 (en) 2012-05-08 2016-08-02 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory disorders
US9233161B2 (en) 2012-05-10 2016-01-12 Cellix Bio Private Limited Compositions and methods for the treatment of neurological conditions
WO2013168015A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of asthma and allergy
US9339484B2 (en) 2012-05-10 2016-05-17 Cellix Bio Private Limited Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US9573927B2 (en) 2012-05-10 2017-02-21 Cellix Bio Private Limited Compositions and methods for the treatment of severe pain
US9403857B2 (en) 2012-05-10 2016-08-02 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US9242939B2 (en) 2012-05-10 2016-01-26 Cellix Bio Private Limited Compositions and methods for the treatment of respiratory disorders
US9346742B2 (en) 2012-05-10 2016-05-24 Cellix Bio Private Limited Compositions and methods for the treatment of fibromyalgia pain
US9273061B2 (en) 2012-05-10 2016-03-01 Cellix Bio Private Limited Compositions and methods for the treatment of chronic pain
US9499526B2 (en) 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of neurologic diseases
WO2013167999A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurologic diseases
WO2013168014A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of familial amyloid polyneuropathy
WO2013167997A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of metabolic syndrome
WO2013168001A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
US9434729B2 (en) 2012-05-23 2016-09-06 Cellix Bio Private Limited Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
WO2013175347A2 (en) * 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of respiratory disorders
JP2015518854A (ja) 2012-05-23 2015-07-06 セリックスビオ プライヴェート リミテッド 多発性硬化症の治療のための組成物および方法
SG11201407326XA (en) 2012-05-23 2014-12-30 Cellix Bio Private Ltd Compositions and methods for treatment of mucositis
WO2013175376A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of local pain
NZ701832A (en) 2012-05-23 2016-08-26 Cellix Bio Private Ltd Compositions and methods for treatment of inflammatory bowel disease
US9108942B1 (en) 2014-11-05 2015-08-18 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
US9187427B2 (en) 2012-08-03 2015-11-17 Cellix Bio Private Limited N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases
WO2014037833A2 (en) 2012-09-06 2014-03-13 Mahesh Kandula Compositions and methods for the treatment inflammation and lipid disorders
AU2013311349A1 (en) 2012-09-08 2014-11-27 Cellixbio Private Limited Compositions and methods for treatment of inflammation and lipid disorders
US9333187B1 (en) 2013-05-15 2016-05-10 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
AU2014276346A1 (en) 2013-06-04 2015-12-24 Cellixbio Private Limited Compositions and methods for the treatment of diabetes and pre-diabetes
US9096537B1 (en) 2014-12-31 2015-08-04 Mahesh Kandula Compositions and methods for the treatment of mucositis
SG11201706952VA (en) 2014-09-26 2017-10-30 Cellix Bio Private Ltd Compositions and methods for the treatment of epilepsy and neurological disorders
EP3201168B1 (en) 2014-09-29 2020-03-18 Cellix Bio Private Limited Compounds and compositions for the treatment of multiple sclerosis
AU2014414316B2 (en) 2014-10-27 2020-04-09 Cellix Bio Private Limited Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
US9321716B1 (en) 2014-11-05 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US10208014B2 (en) 2014-11-05 2019-02-19 Cellix Bio Private Limited Compositions and methods for the treatment of neurological disorders
US9173877B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Compositions and methods for the treatment of local pain
US9175008B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Prodrugs of anti-platelet agents
US9284287B1 (en) 2014-11-05 2016-03-15 Cellix Bio Private Limited Compositions and methods for the suppression of carbonic anhydrase activity
US9150557B1 (en) 2014-11-05 2015-10-06 Cellix Bio Private Limited Compositions and methods for the treatment of hyperglycemia
US9290486B1 (en) 2014-11-05 2016-03-22 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy
WO2016088132A1 (en) 2014-12-01 2016-06-09 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
US9206111B1 (en) 2014-12-17 2015-12-08 Cellix Bio Private Limited Compositions and methods for the treatment of neurological diseases
JP6679616B2 (ja) 2015-01-06 2020-04-22 セリックス バイオ プライヴェート リミテッドＣｅｌｌｉｘ Ｂｉｏ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ 炎症及び疼痛の治療のための組成物及び方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432904A (en) * 1973-08-24 1976-04-22 Uriach & Cia Sa J N-2-n-cyclohexyl-n-methylaminomethyl-4,6-dibromo-phenyl-benzamides methods for their preparation and compositions containing them
FR2399276A1 (fr) * 1977-08-03 1979-03-02 Rhone Poulenc Ind Procede de fabrication de billes d'alumine
CA1117546A (en) * 1978-03-02 1982-02-02 John D. Spivack Hydrolytically stable ortho-alkylated phenyl phosphonites and stabilized compositions
IT1094864B (it) * 1978-05-29 1985-08-10 Tosi Franco Ist Derivati della bromexina e procedimento per la loro preparazione
DK110582A (da) * 1981-03-19 1982-09-20 Hokuriku Pharmaceutical 2-benzoylamino-substituerede benzylaminderivater samt fremgangsmaade til fremstilling af samme
IT1213132B (it) * 1984-02-02 1989-12-14 Yason Srl Agente antibroncopneumopatico.

Also Published As

Publication number Publication date
IT9020562A1 (it) 1991-12-06
CA2083597A1 (en) 1991-12-07
EP0532644A1 (en) 1993-03-24
US5352703A (en) 1994-10-04
JPH05506450A (ja) 1993-09-22
ES2061252T3 (es) 1994-12-01
DE69104723T2 (de) 1995-02-23
WO1991018865A1 (en) 1991-12-12
EP0532644B1 (en) 1994-10-19
DE69104723D1 (de) 1994-11-24
IT9020562A0 (enExample) 1990-06-06
ATE113029T1 (de) 1994-11-15

Similar Documents

Publication Publication Date Title
ATE113029T1 (de) Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
SE9003712L (sv) Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
IT1252868B (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
ZA948670B (en) New benzoyl guanidine derivatives,the preparation thereof and their use in pharmaceutical compositions
SE8300736D0 (sv) Novel pharmacologically active compounds
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
DK0858328T3 (da) Stabile præparater indeholdende N-propargyl-1-aminoindan
ATE60759T1 (de) Bisdimethoxymethyl(trimethoxybenzyl)isochinolinium salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE59406938D1 (de) Pharmazeutische zubereitungen mit einem wirkstoff, der modifizierte amidingruppen enthält
IL98133A0 (en) Sulphonyl substituted benzo-naphthyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
SE8804628D0 (sv) New compounds
SE9402880D0 (sv) New peptide derivatives
ATE107167T1 (de) Pharmazeutische zubereitungen für neuroschutz, die arylcyclohexylamine enthalten.
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
NO306400B1 (no) N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
EP0291269A3 (en) Anti-tumour sulfonyl urea derivatives
IT1276781B1 (it) Derivati antrachinonmono- e disolfon- sostituiti e composizioni farmaceutiche che li contengono per il trattamento delle patologie
SE8904127D0 (sv) New biocyclic amino-substituted compounds
NO950177L (no) Farmakologisk aktive erivater
ZA9429B (en) Pyrrolidine derivatives their preparation and medicaments containing them
IL107520A0 (en) Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them
TW248530B (enExample)
SE9604752D0 (sv) Formulation and use

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960627